New additions to Germany's thriving biotechnology industry
Roche Germany has opened a new, five-storey biotechnology production plant in Penzberg, Bavaria. The building is an addition to Roche's existing facilities in the town. It is also one of five current projects at the site, which is home to one of the largest biotech centers in Europe.
During the past three years, Roche has invested around EUR 600 million in Penzberg to build a new laboratory and office complex, a diagnostics production plant, and new infrastructure for energy generation and other resources. Further plant and wastewater facilities were expanded as well. Penzberg is the only Roche site in the world where R&D and production for diagnostics and pharmaceuticals take place in parallel.
Work at the site is dedicated to, among other things, discovering and developing new protein-based drugs, including next generation antibodies. For example, the company's Antibody Powerhouse encompasses the entire value chain including production, supplying almost all the Roche group’s business areas with highly specific antibodies. Roche Personalized Healthcare's biomarker program is another activity based on the site.
At the building's inauguration, Bavarian State Premier Horst Seehofer said, "Government investments over the past decade are now bearing fruit. Bavaria is the number one biotechnology location in Germany today." According to Roche Chairman Christoph Franz the company's investments enhance the role of Roche Germany as a major innovation site within the Roche group. Franz continued, "The German facilities make a significant contribution to Roche's economic success."
Bavaria has biotechnology clusters of excellence located all around the state. BioM is the network organization of the biotechnology sector in Munich and Bavaria. It is the place to start when seeking information about biotechnology in the region.